Met deze subsidie wordt publiek-private samenwerking gestimuleerd. Deze toeslag is door Topsector Life Sciences & Health beschikbaar gesteld aan Longfonds, ter stimulatie van publiek-private samenwerkingen.
Public-Private Partnership allowance
Health~Holland (Top Sector Life Sciences and Health) and the Lung Foundation enable consortia of researchers and companies to apply for a grant (Public-Private Partnership(PPP) allowance) for basic, translational or applied research. Research projects have to contribute to the goals and objectives of both the Topsector LSH and the Lung Foundation.
Lung Foundation aims
The Lung Foundation works with three main research themes, divided into different (non-exclusive) topics (“research agenda”): 1) Prevention of lung diseases and lung damage; 2) Diagnosis of lung disease: earlier, more specific, and guiding treatment; and 3) Care and treatment: innovative and personalized. The PPP funding allocated to the Lung Foundation will be used for proposals that fit these themes.
The topsector LSH has designed roadmaps to address priorities in health outcomes (age-related, chronic, acute, infectious, orphan and neglected diseases) and along the healthcare chain (from prevention through diagnosis to cure and care). The roadmaps represent the areas in which public and private parties are committed to co-innovate. Research proposals will have to fit one of these roadmaps.
The PPP-funds are meant to stimulate economic activity in the health sector. Therefore, companies should participate in the project consortium in such a way that their involvement provides an added value to the project.
In contrast to last year, the Lung Foundation will only consider research proposals for funding that fit the research categories industrial research and experimental research. For industrial research, funding is maximized at 50% of the total eligible project costs, and for experimental development this is 25%. Research in projects is often a combination of fundamental, industrial and experimental research. A (smaller) part of the project can still be fundamental research. Universities and/or the companies have to finance the remaining part of the project costs, either in kind or in cash.
Note: the Lung Foundation will not provide additional funding to support project costs not covered by the PPP grant.
In order to stimulate the public-private partnership, the participating companies should provide a minimum of 15% of the eligible project costs, either in cash or in kind (for small and medium companies). When large companies are involved 2/3 of the 15% of the eligible costs should be provided in cash (10% of total eligible project costs).
The consortium has to sign a consortium agreement following the PPP-allowance regulation. This agreement describes agreements of the partners on intellectual property rights and the roles and contributions of each of the partners.
The Ministry of Economic Affairs, Health~Holland and the Longfonds offer a unique opportunity to the lung research community to obtain funding for economically viable research. The Longfonds believes that economically viable research will also benefit patients and is therefore willing to facilitate and enable a successful application procedure.
For more information or questions you could contact the research department by email or phone 0031 (0) 33 43 41 253.